Premaitha Health Plc (NIPT)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Premaitha Health Plc (NIPT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013373
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that assists in estimating the risk of trisomy. The IONA test helps obviate the expensive, unnecessary and invasive diagnostic procedures such as amniocentesis. The company provides NIPT tests and services to clinical laboratories and healthcare professionals. Premaitha Health offers its products directly to customers in Europe. It operates through a subsidiary, Yourgene Bioscience, in Taiwan, which provides it expanded market access in Asia. Premaitha Health is headquartered in Manchester, England, the UK.

Premaitha Health Plc (NIPT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Premaitha Health Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Premaitha Health Plc, Medical Devices Deals, 2011 to YTD 2017 9
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sagentia Enters into Agreement with Premaitha Health to Develop IONA Test for Prenatal Screening 11
Equity Offering 12
Premaitha Health Raises USD12.5 Million in Private Placement of Shares 12
Premaitha Raises USD12 Million in Private Placement of Shares 13
Acquisition 14
Premaitha Health Acquires Yourgene Bioscience for USD9 Million 14
Premaitha Health Plc – Key Competitors 15
Premaitha Health Plc – Key Employees 16
Premaitha Health Plc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Sep 29, 2017: Premaitha Health: Full year results to 31 March 2017 and half-year trading update 18
Dec 21, 2016: Premaitha Health: Half Year Results 20
Sep 30, 2016: Premaitha Health: Annual Results 2016 22
Corporate Communications 23
Sep 08, 2016: Premaitha Health Announces Directorate Change 23
Jul 06, 2016: Premaitha Health Announces Directorate Change 24
Legal and Regulatory 25
Jul 03, 2017: Premaitha Health Litigation Update 25
Jul 04, 2016: Premaitha Health: Progress on anti-trust objections to litigation 26
Jan 26, 2016: Premaitha Health: Update on UK Litigation Timing 27
Other Significant Developments 28
Jun 05, 2017: Premaitha Health: India Business Update 28
May 12, 2017: Premaitha Health: Update Re. Swiss Customer 29
Feb 07, 2017: Premaitha Health: Southern Europe Business Update 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Premaitha Health Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Premaitha Health Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Premaitha Health Plc, Deals By Therapy Area, 2011 to YTD 2017 8
Premaitha Health Plc, Medical Devices Deals, 2011 to YTD 2017 9
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sagentia Enters into Agreement with Premaitha Health to Develop IONA Test for Prenatal Screening 11
Premaitha Health Raises USD12.5 Million in Private Placement of Shares 12
Premaitha Raises USD12 Million in Private Placement of Shares 13
Premaitha Health Acquires Yourgene Bioscience for USD9 Million 14
Premaitha Health Plc, Key Competitors 15
Premaitha Health Plc, Key Employees 16
Premaitha Health Plc, Subsidiaries 17

★海外企業調査レポート[Premaitha Health Plc (NIPT)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 2020 GeneSystems Inc-製薬・医療分野:企業M&A・提携分析
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. The company provides tests in the areas such as personalized medicine, earl …
  • Bank of Kaohsiung, Ltd.:企業の戦略・SWOT・財務情報
    Bank of Kaohsiung, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Kaohsiung, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bauer AG (B5A):企業の財務・戦略的SWOT分析
    Bauer AG (B5A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • Ashland Global Holdings Inc (ASH):企業の財務・戦略的SWOT分析
    Ashland Global Holdings Inc (ASH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Svenska Cellulosa Aktiebolaget:企業の戦略・SWOT・財務分析
    Svenska Cellulosa Aktiebolaget - Strategy, SWOT and Corporate Finance Report Summary Svenska Cellulosa Aktiebolaget - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Woolworths Holdings Limited:戦略・SWOT・企業財務分析
    Woolworths Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Woolworths Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Flowserve Corporation:企業の戦略・SWOT・財務情報
    Flowserve Corporation - Strategy, SWOT and Corporate Finance Report Summary Flowserve Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development:製薬・医療:M&Aディール及び事業提携情報
    Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health, is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the …
  • AirAsia Berhad:企業の戦略・SWOT・財務情報
    AirAsia Berhad - Strategy, SWOT and Corporate Finance Report Summary AirAsia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • DHL Supply Chain (formerly Exel Inc.):戦略・SWOT・企業財務分析
    DHL Supply Chain (formerly Exel Inc.) - Strategy, SWOT and Corporate Finance Report Summary DHL Supply Chain (formerly Exel Inc.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Utair Aviation:企業の戦略・SWOT・財務分析
    Utair Aviation - Strategy, SWOT and Corporate Finance Report Summary Utair Aviation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • AMEWAS, Inc.:企業の戦略・SWOT・財務情報
    AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Canon Medical Systems Corp:企業の戦略的SWOT分析
    Canon Medical Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mauna Kea Technologies SAS (MKEA)-医療機器分野:企業M&A・提携分析
    Summary Mauna Kea Technologies SAS (MKT) is a medical device company that develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. The company’s product includes cellvizio. Its cellvizio is an endomicroscopy platform that provides micr …
  • Aromatech SAS:企業の戦略・SWOT・財務情報
    Aromatech SAS - Strategy, SWOT and Corporate Finance Report Summary Aromatech SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Valecha Engineering Ltd:企業の戦略・SWOT・財務分析
    Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • RadiSys Corp (RSYS):企業の財務・戦略的SWOT分析
    Summary RadiSys Corp (RadiSys) is a provider of communication services. The company offers products include mobility engine, mediaengine, dcengine and embedded Products. It offers contact support, serviceengine, conceptualization, software customization, network design and integration; testing and a …
  • MacroGenics Inc (MGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary MacroGenics Inc (MacroGenics) is a clinical-stage biopharmaceutical company which focuses on the discovery, development and delivery of novel antibody-based therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders. Its pipeline includes product candidates for th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆